Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Beger

Showing results (11-20 of 115) with videos related to

Pageof 12
Sort By:
Journal of Chemical Information and Computer Sciences|July 27, 2004
Models of steroid binding based on the minimum deviation of structurally assigned 13C NMR spectra analysis (MiDSASA)Richard D Beger, Stephen Harris, Qian Xie
Archives of Toxicology|February 29, 2020
Determination of structural factors affecting binding to mu, kappa and delta opioid receptorsSvetoslav Slavov, William Mattes, Richard D Beger
Seminars in Nephrology|December 7, 2007
Metabolomics as an extension of proteomic analysis: study of acute kidney injuryDidier Portilla, Laura Schnackenberg, Richard D Beger
Environmental Toxicology and Chemistry|March 12, 2003
The use of carbon thirteen nuclear magnetic resonance spectra to predict dioxin and furan binding affinities to the aryl hydrocarbon receptorLindsay Shade, Richard D Beger, Jon G Wilkes
Personalized Medicine|May 23, 2018
Metabolomics: a tool for personalizing medicine?Laura K Schnackenberg, Jim Kaput, Richard D Beger
Journal of Chemical Information and Computer Sciences|May 25, 2004
Discriminant function analyses of liver-specific carcinogensRichard D Beger, John F Young, Hong Fang
Methods in Molecular Biology (Clifton, N.J.)|July 25, 2024
Identification of Proteomic Biomarkers of Acetaminophen-Induced Hepatotoxicity Using Stable Isotope LabelingLi-Rong Yu, Yuan Gao, Richard D Beger
Personalized Medicine|May 16, 2018
Metabolomics as a tool for personalizing medicine: 2012 updateJinchun Sun, Richard D Beger, Laura K Schnackenberg
Toxicology and Applied Pharmacology|November 26, 2009
Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicityRichard D Beger, Jinchun Sun, Laura K Schnackenberg
Drug Metabolism Letters|August 26, 2009
Studies of acetaminophen and metabolites in urine and their correlations with toxicity using metabolomicsJinchun Sun, Laura K Schnackenberg, Richard D Beger
Pageof 12

Showing results (11-20 of 115) with videos related to

Sort By:
Pageof 12
Journal of Chemical Information and Computer Sciences|July 27, 2004
Models of steroid binding based on the minimum deviation of structurally assigned 13C NMR spectra analysis (MiDSASA)Richard D Beger, Stephen Harris, Qian Xie
Archives of Toxicology|February 29, 2020
Determination of structural factors affecting binding to mu, kappa and delta opioid receptorsSvetoslav Slavov, William Mattes, Richard D Beger
Seminars in Nephrology|December 7, 2007
Metabolomics as an extension of proteomic analysis: study of acute kidney injuryDidier Portilla, Laura Schnackenberg, Richard D Beger
Environmental Toxicology and Chemistry|March 12, 2003
The use of carbon thirteen nuclear magnetic resonance spectra to predict dioxin and furan binding affinities to the aryl hydrocarbon receptorLindsay Shade, Richard D Beger, Jon G Wilkes
Personalized Medicine|May 23, 2018
Metabolomics: a tool for personalizing medicine?Laura K Schnackenberg, Jim Kaput, Richard D Beger
Journal of Chemical Information and Computer Sciences|May 25, 2004
Discriminant function analyses of liver-specific carcinogensRichard D Beger, John F Young, Hong Fang
Methods in Molecular Biology (Clifton, N.J.)|July 25, 2024
Identification of Proteomic Biomarkers of Acetaminophen-Induced Hepatotoxicity Using Stable Isotope LabelingLi-Rong Yu, Yuan Gao, Richard D Beger
Personalized Medicine|May 16, 2018
Metabolomics as a tool for personalizing medicine: 2012 updateJinchun Sun, Richard D Beger, Laura K Schnackenberg
Toxicology and Applied Pharmacology|November 26, 2009
Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicityRichard D Beger, Jinchun Sun, Laura K Schnackenberg
Drug Metabolism Letters|August 26, 2009
Studies of acetaminophen and metabolites in urine and their correlations with toxicity using metabolomicsJinchun Sun, Laura K Schnackenberg, Richard D Beger
Pageof 12